| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.032 | 0.4 |